Table 3:
Patient No. | ISSON Width |
ISSON Width (Gross Visual Inspection) |
|||||||
---|---|---|---|---|---|---|---|---|---|
Position 1 |
Position 2 |
Position 3 |
Position 4 |
||||||
–/N | MM | –/N | MM | –/N | MM | –/N | MM | –/N | |
1 | N | 1.1 | – | 0 | – | 0 | – | 0 | – |
2 | – | N.A. | – | 0.6 | – | 0.6 | – | 0.7 | – |
3 | N | 1.2 | N | 1.1 | – | 0.7 | – | 0.8 | – |
4 | – | 0 | – | 0 | – | 0 | – | 0 | – |
5 | – | 0 | – | 0 | – | 0 | – | 0 | – |
6 | – | 0 | – | 0 | – | 0 | – | 0 | – |
7 | – | 0 | – | 0 | – | 0 | – | 0 | – |
8 | – | 0 | – | 0 | – | 0 | – | 0 | – |
9 | N | 1.6 | N | 0.9 | – | 0.7 | – | 0 | – |
10 | N | 1.2 | – | 0.6 | – | 0.7 | – | 0 | – |
11 | – | 0.8 | – | 0 | – | 0 | – | 0.8 | – |
12 | N | 1.1 | – | 0 | – | 0 | – | 0 | – |
13 | – | 0 | – | 0 | – | 0 | – | 0 | – |
14 | N | 1.2 | – | 0 | – | 0 | – | 0 | – |
15 | – | 0.8 | – | 0 | – | 0 | – | 0 | – |
16 | – | 0.7 | – | 0 | – | 0 | – | 0 | – |
17 | – | 0 | – | 0 | – | 0 | – | 0 | – |
18 | N | 1.4 | N | 1.2 | – | 0.7 | – | 0 | – |
19 | – | 0 | – | 0 | – | 0 | – | 0 | – |
Mean | 0.6 | 0.2 | 0.2 | 0.1 | |||||
SD | 0.6 | 0.4 | 0.3 | 0.3 | |||||
Sensitivity | 61% | 84% | 100% | 100% | 100% | ||||
CI (95%) | 36%–83% | 60%–97% | 85%–100% | 85%–100% | 85%–100% | ||||
ICCc | 0.908 | 0.859 | 0.862 | 0.824 | |||||
κc | 1 |
Measurements were obtained in 4 intraorbital positions approximately 3, 6, 10, and 20 mm behind the eyeball. Specificity was 97% each.
–indicates decreased (<1.0 mm, [position 1]; <0.9 mm, [positions 2–4]). Regarding gross visual inspection,–corresponds to a reduction or absence of CSF in the ISSON.
ICC and κ values were computed for results of 3 readers.